Presentation by Dr Alexandre Erler, from the ACT research team, at the 31st European Conference on Philosophy of Medicine and Healthcare. Topic: ethical issues related to uses of the technology of 3D bioprinting "beyond therapy", including uses by "biohackers" that would involve a form of DiDIY.
One of the main limitations of 3D printing is its "slowness". Often, though, this is an issue only when one actually needs to manufacture many identical copies of the same object. Still, it is an issue.
“3d Printing Will Be Able to Mature in Places Where Production Infrastructure Is Broken”
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 644344. Disclaimer: The views expressed in this website do not necessarily reflect the views of the EC.